Abstract
Thirty preterm infants (birthweight under 1500 g) were treated with phenobarbitone to examine its effectiveness in reducing the incidence of intraventricular haemorrhage (IVH), the control group comprising 28 infants. The treated group had 57% incidence of IVH and mortality of 13% compared with 68% and 14%, respectively, in controls.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bedard M. P., Shankaran S., Slovis T. L., Pantoja A., Dayal B., Poland R. L. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants. Pediatrics. 1984 Apr;73(4):435–439. [PubMed] [Google Scholar]
- Donn S. M., Roloff D. W., Goldstein G. W. Prevention of intraventricular haemorrhage in preterm infants by phenobarbitone. A controlled trial. Lancet. 1981 Aug 1;2(8240):215–217. doi: 10.1016/s0140-6736(81)90470-0. [DOI] [PubMed] [Google Scholar]
- Morgan M. E., Massey R. F., Cooke R. W. Does phenobarbitone prevent periventricular hemorrhage in very low-birth-weight babies?: a controlled trial. Pediatrics. 1982 Aug;70(2):186–189. [PubMed] [Google Scholar]
- Whitelaw A., Placzek M., Dubowitz L., Lary S., Levene M. Phenobarbitone for prevention of periventricular haemorrhage in very low birth-weight infants. A randomised double-blind trial. Lancet. 1983 Nov 19;2(8360):1168–1170. doi: 10.1016/s0140-6736(83)91217-5. [DOI] [PubMed] [Google Scholar]